Human Cancer-Associated Mutations in the Aα Subunit of Protein Phosphatase 2A Increase Lung Cancer Incidence in Aα Knock-In and Knockout Mice
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Strong evidence has indicated that protein phosphatase 2A (PP2A) is a tumor suppressor, but a mouse model for testing the tumor suppressor activity was missing. The most abundant forms of trimeric PP2A holoenzyme consist of the scaffolding Aα subunit, one of several regulatory B subunits, and the catalytic Cα subunit. Aα mutations were discovered in a variety of human carcinomas. All carcinoma-associated mutant Aα subunits are defective in binding the B or B and C subunits. Here we describe two knock-in mice expressing cancer-associated Aα point mutants defective in binding B' subunits, one knockout mouse expressing truncated Aα defective in B and C subunit binding, and a floxed mouse for generating conditional Aα knockouts. We found that the cancer-associated Aα mutations increased the incidence of cancer by 50 to 60% in lungs of FVB mice treated with benzopyrene, demonstrating that PP2A acts as a tumor suppressor. We show that the effect of Aα mutation on cancer incidence is dependent on the tumor suppressor p53. The finding that the Aα mutation E64D, which was detected in a human lung carcinoma, increases the lung cancer incidence in mice suggests that this mutation also played a role in the development of the carcinoma in which it was discovered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, recurrent mutation of these residues (for example, P179, R183, S256, and R258) result in marked changes in the PP2A holoenzyme composition in cells (Haesen et al., 2016; O’Connor et al., 2019; Ruediger et al., 2011; Taylor et al., 2019).”
From Selective PP2A enhancement through biased heterotrimer stabilization (2020) · cites this paper as Ruediger et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In line with the observations from Cα KO mice, constitutive KO of Ppp2r1a in two different models resulted in embryonic lethality between E5 and E10.5 [10,36].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in an in vivo knockin model of the cancer-associated E64G Aα mutant, defective in B56α and B56δ (and potentially other B56 isoforms) binding [10,93], there was no impact on retina structure and function.”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More importantly, knockout (KO) studies in mice have revealed that the homozygous deletion of PPP2R1A and PPP2CA is embryonically lethal [ 36 – 38 ].”
From Targeting PP2A in cancer: an underrated option (2025) · cites this paper as [36]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For instance, the Aα E64G and E64D mutants, respectively discovered in breast and lung carcinoma [104], were found to be defective in B56α and B56δ binding in vivo [10], and B56γ binding in vitro [93].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [10]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, W., Arroyo, J. D., Timmons, J. C., Possemato, R., & Hahn, W. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1103 · Cited by 159 · cited 8×
“Conversely, overexpression of B reverts SV40-STdependent transformation (7, 8).”
BackgroundResultInfluentialRetractedRepbase Update, a database of eukaryotic repetitive elements
Jurka, J., Kapitonov, V. V., Pavlicek, A., Klonowski, P., Kohany, O., & Walichiewicz, J. (2005) · Cytogenetic and Genome Research · doi:10.1159/000084979 · Cited by 3,370
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,902 · cited 2×
“Protein phosphatase 2A (PP2A) plays a role in many fundamental cellular processes, such as signal transduction, DNA repair, transcription, translation, and growth control (15, 24, 26, 43, 77).”
BackgroundHayashi, S., & McMahon, A. P. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0597 · Cited by 1,342 · cited 2×
“receptor (ER) that binds tamoxifen (TM) but not endogenous estrogen (21).”
BackgroundFrequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219 · cited 1×
“In a third ovarian cancer, arginine 182 is mutated to tryptophan (27).”
BackgroundA one-step purification of membrane proteins using a high efficiency immunomatrix.
Schneider, C., Newman, R. A., Sutherland, D. R., Asser, U., & Greaves, M. F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33889-4 · Cited by 764 · cited 1×
“were coupled to monoclonal antibody 6F9 as described previously (60).”
MethodCIP2A inhibits PP2A in human malignancies
Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677 · cited 1×
“Further evidence that PP2A is a tumor suppressor comes from the discovery that the B holoenzyme plays a key role in Myc degradation (2) and from the identification of an inhibitor, CIP2A, which binds to PP2A and Myc, thus preventing PP2A from dephosphorylating Myc at serine 62, a prerequisite for Myc degradation (28).”
BackgroundEnumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation
Hahn, W. C., Dessain, S. K., Brooks, M. W., King, J. E., Elenbaas, B., Sabatini, D. M., DeCaprio, J. A., & Weinberg, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2111-2123.2002 · Cited by 612 · cited 3×
“An important discovery was that SV40-ST is required for the transformation of primary human cells in combination with SV40 large T antigen, H-ras, and telomerase (20, 80).”
BackgroundWidespread recombinase expression using FLPeR (Flipper) mice
Farley, F. W., Soriano, P., Steffen, L. S., & Dymecki, S. M. (2000) · genesis · doi:10.1002/1526-968x(200011/12)28:3/4<106::aid-gene30>3.0.co;2-t · Cited by 610 · cited 3×
“The CreER mouse was obtained from The Jackson Laboratory (catalog number 004682).”
MethodInfluentialOkadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
Suganuma, M., Fujiki, H., Suguri, H., Yoshizawa, S., Hirota, M., Nakayasu, M., Ojika, M., Wakamatsu, K., Yamada, K., & Sugimura, T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.6.1768 · Cited by 597 · cited 1×
“The first indication that PP2A might be a tumor suppressor came from the finding that okadaic acid is both a tumor promoter and an inhibitor of PP2A (18, 25, 43, 69, 77).”
Background
Cited by
Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore
Foley, E. A., & Kapoor, T. M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3494 · Cited by 636
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Seshacharyulu, P., Pandey, P., Datta, K., & Batra, S. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.036 · Cited by 481
“Based on the mutations E64G and E64D, four different mouse strains were developed by Ruediger et al 2011: knock-in models E64D/ + and E64G/+; conditional Aα knock-out F5-6/+ with exon 5 and 6 floxed for Aα allele; and Δ5-6/+ was harboring exon 5 and 6 deletion in the Aα allele.”
BackgroundMethodInfluentialProtein phosphatase 2A: a target for anticancer therapy
Perrotti, D., & Neviani, P. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70558-2 · Cited by 400
All roads lead to PP 2A: exploiting the therapeutic potential of this phosphatase
Sangodkar, J., Farrington, C. C., McClinch, K., Galsky, M. D., Kastrinsky, D. B., & Narla, G. (2016) · The FEBS Journal · doi:10.1111/febs.13573 · Cited by 312
Phosphatase PP2A is requisite for the function of regulatory T cells
Apostolidis, S. A., Rodríguez-Rodríguez, N., Suárez-Fueyo, A., Dioufa, N., Ozcan, E., Crispín, J. C., Tsokos, M. G., & Tsokos, G. C. (2016) · Nature Immunology · doi:10.1038/ni.3390 · Cited by 238
Metadata
- Authors
- Ruediger, R., Ruiz, J., & Walter, G.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Walter, Gernot
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2011-09
- Volume
- 31
- Issue
- 18
- Pages
- 3832-3844
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3165721
- OpenAlex
- W2121528020
- Cited by
- 98
- References
- 86
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 11 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 7 · 2014: 8 · 2013: 6 · 2012: 7
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tobacco-Related Disease Research Program
- U.S. Public Health Service
- University of California, San Diego
- National Cancer Institute (R01CA118015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- protein phosphatase 2A, tumor suppressor, lung cancer, cancer-associated mutations, benzopyrene, p53, knock-in mice, knockout mice, floxed mice, carcinogenesis
- MeSH terms
- Adenocarcinoma of Lung, Adenocarcinoma, Animals, Base Sequence, Benzopyrenes, Disease Models, Animal, Humans, Lung Neoplasms, Mice, Transgenic, Mutation, Incidence, Tumor Suppressor Protein p53, Point Mutation, Sequence Analysis, DNA, Mice, Knockout, Protein Isoforms, Protein Subunits, Tumor Suppressor Proteins, Mice, Protein Phosphatase 2, Gene Knock-In Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Cancer-Associated Mutations in the Aα Subunit of Protein Phosphatase 2A Increase Lung Cancer Incidence in Aα Knock-In and Knockout Mice. https://app.cochat.ai/papers/10.1128/mcb.05744-11
- The paper
- Ruediger, R., Ruiz, J., & Walter, G. (2011). Human Cancer-Associated Mutations in the Aα Subunit of Protein Phosphatase 2A Increase Lung Cancer Incidence in Aα Knock-In and Knockout Mice. Molecular and Cellular Biology. https://doi.org/10.1128/mcb.05744-11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.